Search
Metyrapone
go.drugbank.com/drugs/DB01011ApprovedInvestigationalIt is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of cushing syndrome.
Categories: Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A InducersProducts: Metycor 250 mg WeichkapselnOxidronic acid
go.drugbank.com/drugs/DB14159ApprovedProducts: TECHNESCAN HDP FOR INJECTION 3 mg/vial, TECHNESCAN HDP POWDER FOR INJECTION 3.15 mg/vialTelbivudine
go.drugbank.com/drugs/DB01265ApprovedWithdrawnTelbivudine is a synthetic thymidine nucleoside analog with specific activity against the hepatitis B virus. Telbivudine is orally administered, with good tolerance, lack of toxicity and no dose-limiting side effects.
Synonyms: 1-(2-deoxy-β-L-ribofuranosyl)-5-methyluracilProducts: SEBIVO (600 MG), SEBIVO 600 MG FILM KAPLI TABLET, 28 ADETMoroctocog alfa
go.drugbank.com/drugs/DB13999ApprovedMoroctocog alfa is produced through recombinant DNA technology and purification, resulting in a 1438 amino acid, 170 kDa protein [L41170]. … Use of recombinant DNA-derived clotting factor treatments, such as Moroctocog alfa, has reduced this risk.
Products: Xyntha 500 IU Powder and Solvent for Solution for Injection, XYNTHA ® 500 UI POLVO LIOFILIZADO PARA SOLUCIÓN INYECTABLEVasopressin
go.drugbank.com/drugs/DB00067ApprovedInvestigational[A228008, A228013, A228018, L31413] The vasopressive effect of posterior pituitary gland extracts was noted in 1895, while vasopressin itself was not purified until 1951. … It has been used for more than five decades for varying conditions, including variceal bleeding, diabetes insipidus, and, more recently, vasodilatory shock.
Products: Pitressin Inj 10 Unit/0.5ml, VASOPRESINA 20 UI/MLLevomethadone
go.drugbank.com/drugs/DB13515InvestigationalProducts: Levo-Methasan 10 mg-Tabletten, L-Polamidon 5 mg TablettenGemtuzumab ozogamicin
go.drugbank.com/drugs/DB00056ApprovedInvestigationalGemtuzumab ozogamicin has approximately 50% of the antibody loaded with 4-6 moles calicheamicin per mole of antibody [FDA Label]. … Marketing approval of gemtuzumab ozogamicin was granted on May 17, 2000 by FDA as a treatment for patients with CD33-positive AML in first relapse who are 60 years of age or older and who are not considered
Products: MYLOTARG 5 MG IV İNFÜZYONLUK ÇÖZELTİ HAZIRLAMADA KULLANILACAK KONSANTRE İÇİN TOZ, 1 FLAKON, MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIALAcipimox
go.drugbank.com/drugs/DB09055ApprovedInvestigationalFlushing can be reduced by taking aspirin 20-30 min before taking Acipimox. High doses can cause disorders of liver function, impair glucose tolerance and precipitate gout. … Acipimox is a niacin derivative used as a hypolipidemic agent.
Products: OLBETAM CAPSULE 250 mgLapatinib
go.drugbank.com/drugs/DB01259ApprovedInvestigationalLapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. … It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine.
Synonyms: N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamineCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 SubstratesPlantago seed
go.drugbank.com/drugs/DB11097ApprovedInvestigationalRegardless, this agent is most predominantly used as a gentle laxative agent in many parts of the world that is more commonly referred as psyllium or psyllium husk. … Its potential benefit in maintaining remission in ulcerative colitis has been studied [A27156].
Products: Karacil Pwr 50%, Fibre Three Powder 2.4 Gm/ 5.0 Gm